Standard treatment and emerging drugs for managing synovial sarcoma: adult’s and pediatric oncologist perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Standard treatment and emerging drugs for managing synovial sarcoma: adult’s and pediatric oncologist perspective

Published:2019-01-02 Issue:1 Volume:24 Page:43-53
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Baldi Giacomo G.¹,Orbach Daniel²,Bertulli Rossella³,Magni Chiara⁴,Sironi Giovanna⁴,Casanova Michela⁴,Ferrari Andrea⁴

Affiliation:

1. “Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Prato, Italy

2. SIREDO Oncology Center, PSL University, Institut Curie, Paris, France

3. Medical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

4. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2019.1591367

Reference86 articles.

1. The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view

2. Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database

3. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005

4. Considering chemotherapy in synovial sarcoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary renal synovial sarcomas diagnosed by a novel fusion gene with the fusion site involving exons of SS18 and SSX2: a case report;Oncologie;2024-05-22

2. Synovial sarcoma: the misdiagnosed sarcoma;EFORT Open Reviews;2024-03-01

3. Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial;Clinical Cancer Research;2023-10-04

4. Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancer Management and Research;2022-09

5. Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas;Biochemical Pharmacology;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3